|
Wednesday, November 20, 2013
Print Current Day:
 |
|
| SESSION 21 SCHEDULE | |
|
Wednesday
SESSION 21:
PROGRESS IN TRANSCATHETER HEART VALVES AND NEW APPROACHES TO THE ASCENDING AORTA
|
|
| x | |
| 6:45 AM - 6:49 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| 6:49 AM - 6:54 AM | Update On New Endovascular Techniques For Mitral Valve Repair: Status Of The MitraClip, Its Trials (EVEREST II And COAPT) And With The FDA |
| Presenter(s):Ted Feldman, MD | |
| View Abstract | |
| 6:55 AM - 7:00 AM | Vascular Access Complications Are A Major Determinant Of Outcomes After TAVR: What Can Be Done To Decrease These Complications |
| Presenter(s):Patrice B. Mwipatayi, FRACS | |
| 7:01 AM - 7:06 AM | DEBATE:Update On Transcatheter Aortic Valve Replacement (TAVR): Results, Device Improvement And Future Outlook: An Interventional Cardiologist’s View |
| Presenter(s):Ted Feldman, MD | |
| 7:07 AM - 7:12 AM | DEBATE:Update On Transcatheter Aortic Valve Replacement (TAVR): A Cardiac Surgeon’s View Of Its Role In 2013 And The Future |
| Presenter(s):Erno Remsey-Semmelweis, MD, PhD | |
| View Abstract | |
| 7:13 AM - 7:18 AM | Valve-In-Valve Procedures For Failed Aortic Valve Repairs |
| Presenter(s):Ron Waksman, MD | |
| 7:19 AM - 7:24 AM | Valve-In-Valve Procedures After Failed Mitral Valve Repairs |
| Presenter(s):Dietmar H. Koschyk, MD | |
| View Abstract | |
| 7:25 AM - 7:30 AM | Second Generation Devices For TAVR: What Are The Improvements And Will They Help Outcomes |
| Presenter(s):Ted Feldman, MD | |
| 7:31 AM - 7:36 AM | Why And How Stent-Grafts Will Replace Open Surgery For Ascending Aortic Lesions |
| Presenter(s):Matt M. Thompson, MD | |
| 7:37 AM - 7:42 AM | Endovascular Treatment Of Ischemic Complications After Surgical Treatment Of Type A Aortic Dissections |
| Presenter(s):Burkhart Zipfel, MD | |
| 7:43 AM - 7:48 AM | Panel Discussion |
| END OF SESSION 21 | |
| SESSION 22 SCHEDULE | |
|
Wednesday
SESSION 22:
NEW DEVELOPMENTS IN TREATMENT OF THE AORTIC ARCH AND AORTIC DISSECTIONS
Moderators:Juan C. Parodi, MD / Matt M. Thompson, MD
|
|
| x | |
| 7:48 AM - 7:53 AM | Results Of Aortic Arch Repair By TEVAR With The Cook Internally Branched Device |
| Presenter(s):Krassi Ivancev, MD, PhD | |
| View Abstract | |
| 7:54 AM - 7:59 AM | Total Arch Repair With A Novel Branched Endograft: Promising Results With Complicated Arch Dissections Involving Arch Branches: How Does The Graft Work |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| 8:00 AM - 8:05 AM | Bolton Branched Endograft Device For Aortic Arch Repair: Early And Mid-Term Results |
| Presenter(s):Toru Kuratani, MD, PhD | |
| 8:06 AM - 8:11 AM | A New Branched Arch Endograft Introduced Antegrade Via A Transapical Access Without Direct Branch Access: How Does It Work |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| 8:12 AM - 8:17 AM | Adjunctive Techniques For Treating Arch Disease: Precurved Fenestrated Graft With Branches And Buffalo Horn Chimney Stents |
| Presenter(s):Yoshihiko Yokoi, MD | |
| View Abstract | |
| 8:18 AM - 8:23 AM | Endovascular Techniques For Treating Aortic Arch Lesions |
| Presenter(s):Piotr M. Kasprzak, MD | |
| 8:24 AM - 8:29 AM | Adjunctive Techniques To Facilitate Endovascular Repair Of Aortic Dissection With A Tear And Involvement Of The Arch And Its Branches: Hybrid Repairs And Chimneys |
| Presenter(s):Chang Shu, MD | |
| 8:30 AM - 8:35 AM | Prevention, Diagnosis And Treatment Of Retrograde Dissection After TEVAR |
| Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
| View Abstract | |
| 8:36 AM - 8:41 AM | How To Improve Endograft Conformability In The Aortic Arch With TEVAR |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Abstract | |
| 8:42 AM - 8:47 AM | Reinterventions For Late Endograft Migration After TEVAR In The Aortic Arch |
| Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
| View Abstract | |
| 8:48 AM - 8:54 AM | Panel Discussion |
| END OF SESSION 22 | |
| SESSION 23 SCHEDULE | |
|
Wednesday
SESSION 23:
PROGRESS IN TREATING DISEASES OF THE THORACIC AORTA, INCLUDING TYPE B AORTIC DISSECTIONS (TBADs)
Moderators:Michael D. Dake, MD / Rodney A. White, MD
|
|
| x | |
| 8:55 AM - 9:01 AM | DEBATE: Value Of Medical Therapy For Uncomplicated TBAD: It Is Best For Most |
| Presenter(s):Dittmar Boeckler, MD | |
| 9:02 AM - 9:07 AM | DEBATE: Value Of Medical Therapy For Uncomplicated TBAD: It Is Best For Few: TEVAR Is Best For Most |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| 9:08 AM - 9:13 AM | Which Uncomplicated TBAD Should Be Treated By TEVAR And Which By Best Medical Therapy (BMT) |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| 9:14 AM - 9:19 AM | Treatment Of Uncomplicated TBADs: 25% Develop Problems: Factors Predicting Which Patients Will Develop Complication So They Can Get Early TEVAR |
| Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM | |
| View Abstract | |
| 9:20 AM - 9:25 AM | The Surgical Standard For TBADs: When Is Open Surgery The Best Treatment |
| Presenter(s):Hazim J. Safi, MD | |
| 9:26 AM - 9:31 AM | TEVAR Can Be Effective Treatment For Chronic TBADs: For How Long After The Initial Dissection |
| Presenter(s):Toru Kuratani, MD, PhD | |
| 9:32 AM - 9:37 AM | With Acute Complicated TBADs Late Aortic False Lumen Remodeling Persists In The Stented Segment But Not In The Aorta Below That: TEVAR Does Not Prevent Aneurysmal Degeneration |
| Presenter(s):Mark Conrad, MD / Richard P. Cambria, MD | |
| 9:38 AM - 9:43 AM | Endovascular Options In Aortic Dissection When TEVAR Coverage Of The Primary Tear Fails To Obliterate The False Lumen |
| Presenter(s):Peter J. Mossop, MBBS | |
| 9:44 AM - 9:49 AM | Two New Techniques To Occlude Distal False Lumen Back Flow In Chronic TBADs: Plugging Can Work Even With Rupture |
| Presenter(s):Tilo Koelbel, MD, PhD / Sebastian E. Debus, MD, PhD | |
| 9:50 AM - 9:55 AM | Next Frontier For TEVAR And Aortic Dissection Treatment Using An Onlay Aortic Patch |
| Presenter(s):Hans Krankenberg, MD | |
| 9:56 AM - 10:03 AM | Panel Discussion |
| 10:03 AM - 10:20 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN TEVAR AND EVAR
Moderators:Edward B. Diethrich, MD / Ronald M. Fairman, MD
|
|
| x | |
| 10:20 AM - 10:25 AM | Optimizing TEVAR Outcomes By Applying The Results Of The MOTHER Registry To Clinical Practice |
| Presenter(s):Matt M. Thompson, MD | |
| 10:26 AM - 10:31 AM | New Insights From The INSTEAD Trial And The IRAD Registry: How Do They Change Our Understanding Of TBADs And Their Treatment |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| 10:32 AM - 10:37 AM | Progress In The Treatment Of Visceral Ischemia From Acute TBAD |
| Presenter(s):Timur P. Sarac, MD | |
| 10:38 AM - 10:43 AM | Endovascular Repair For Acute TBAD With Visceral Ischemia Is Successful And Durable |
| Presenter(s):Chang Shu, MD | |
| 10:44 AM - 10:49 AM | What Are The Risk Factors For Paraplegia After TEVAR And What Can Be Done To Offset Them |
| Presenter(s):Wei Guo Fu, MD | |
| View Abstract | |
| 10:50 AM - 10:55 AM | What Causes Death In Patients With Uncomplicated TBAD: How Should That Influence Our Treatment |
| Presenter(s):Rodney A. White, MD | |
| 10:56 AM - 11:01 AM | When Does LSA Revascularization Matter: A Selective Approach Is Best Even Though The SVS Guidelines Don’t Agree |
| Presenter(s):Matt M. Thompson, MD | |
| 11:02 AM - 11:07 AM | LSA Transposition And Bypass In Association With TEVAR Are Not Benign Procedures Although They Have Durable Patency |
| Presenter(s):Mark K. Eskandari, MD | |
| View Abstract | |
| 11:08 AM - 11:13 AM | Routine Revascularization Of The Left Subclavian Artery (LSA) For All Zone 2 TEVARs Is Both Unnecessary And Harmful |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| 11:14 AM - 11:19 AM | Aortic Arch Debranching Is Not A Simple Procedure: Tips And Tricks For Doing It Right |
| Presenter(s):William J. Quinones-Baldrich, MD | |
| 11:20 AM - 11:25 AM | Challenges And Solutions For Multiple Arch Pathologies |
| Presenter(s):Dittmar Boeckler, MD | |
| 11:26 AM - 11:31 AM | In The Ongoing Transition From Open Repair To EVAR With Thoracoabdominal Aneurysms (TAAAs): What Situations And Lesions Still Are Best Treated By Open Surgery |
| Presenter(s):Michael J. Jacobs, MD | |
| 11:32 AM - 11:37 AM | How To Pick Patients With Uncomplicated Acute Type B Aortic Dissection Who Are Best Treated By TEVAR |
| Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Abstract | |
| 11:38 AM - 11:43 AM | With EVAR And TEVAR Does The Choice Of Graft Affect Arterial Stiffness And Post-Implantation Syndrome: Is There Any Clinical Significance |
| Presenter(s):Christos D. Liapis, MD | |
| View Abstract | |
| 11:44 AM - 11:49 AM | EVAR Durability: Should It Be An Issue With Newer Endografts For AAA Repair |
| Presenter(s):Giovanni Pratesi, MD | |
| 11:50 AM - 11:59 AM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Wednesday
SESSION 25:
MORE TOPICS RELATING TO ABDOMINAL AND THORACIC AORTIC LESIONS
Moderators:Timur P. Sarac, MD / Michel Makaroun, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | DEBATE: AAA Repair Is Justified In Patients With Chronic Renal Insufficiency: Which Is Better, EVAR Or Open Repair (OR) |
| Presenter(s):Anton N. Sidawy, MD, MPH | |
| 1:06 PM - 1:11 PM | DEBATE: AAA Repair Is Not Justified In Dialysis (ESRD) Patients: Outcomes Of EVAR And OR Don’t Justify It |
| Presenter(s):Rabih A. Chaer, MD | |
| 1:12 PM - 1:17 PM | AAAs Are A Systemic Disease And Therefore Progressive By Nature: What Are The Clinical Implications |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Abstract | |
| 1:18 PM - 1:23 PM | Is There Still A Role For Abdominal Debranching Procedures: What Is It |
| Presenter(s):Ronald M. Fairman, MD | |
| 1:24 PM - 1:29 PM | TEVAR For Acute TBAD Patients Should Be Restricted To Symptomatic Patients And Those With Complications: Based On The Updated ADSORB Trial And Other Data |
| Presenter(s):Jan S. Brunkwall, MD, PhD | |
| 1:30 PM - 1:35 PM | DEBATE: Adventa V 12 Covered Stents (Atrium) Is Best For Treating Aortic Coarctations: Can They Be Used In All Settings |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| 1:36 PM - 1:41 PM | DEBATE: Bare Stent Protected PTA Is Better For Most Aortic Coarctations And Produce Good Long-Term Results |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| 1:42 PM - 1:47 PM | DEBATE: Open Surgical Treatment Is Best For Patients With Aortic Coarctations: Which Ones |
| Presenter(s):Joseph S. Coselli, MD | |
| 1:48 PM - 1:53 PM | Panel Discussion |
| END OF SESSION 25 | |
| SESSION 26 SCHEDULE | |
|
Wednesday
SESSION 26:
CRITICAL EVALUATION OF CAROTID TREATMENT – ACUTE STROKES AND CAROTID ARTERY STENTING (CAS) AS OF NOVEMBER 2013: WHERE ARE THEY GOING
Moderators:Thomas S. Riles, MD / Frank J. Veith, MD
|
|
| x | |
| STATUS OF ACUTE STROKE TREATMENT | |
| 1:54 PM - 1:59 PM | How Well Are The New Endovascular Devices Working For Treatment Of Acute Strokes: Why The Negative Results Of The Recent Trials (MR RESCUE, IMS And SYNTHESIS XP) With The Solitaire, Trevo, Merci And Penumbra Devices May Not Be The Last Word |
| Presenter(s):L. Nelson Hopkins, MD | |
| View Abstract | |
| 2:00 PM - 2:05 PM | Who Could (And Should) Perform Acute Stroke Interventions |
| Presenter(s):Horst Sievert, MD | |
| 2:06 PM - 2:11 PM | Update On Endovascular Techniques And Results Of Carotid And Cerebral Artery Thrombectomy For Acute Strokes: How It Can Be Done Safely And Effectively And What Is The Risk: Experience In >150 Patients |
| Presenter(s):Klaus D. Mathias, MD | |
| STATUS OF CAROTID ARTERY STENTING (CAS) | |
| 2:12 PM - 2:17 PM | Improved Technology For CAS Will Improve CAS Outcomes: Why Membrane/Mesh Covered Stents And Flow Reversal Will Make A Difference: What Is Their Status |
| Presenter(s):Claudio J. Schonholz, MD | |
| 2:18 PM - 2:23 PM | DEBATE: CREST Justifies Increased Usage Of CAS For Symptomatic And Asymptomatic Patients With Carotid Stenosis |
| Presenter(s):William A. Gray, MD | |
| 2:24 PM - 2:29 PM | DEBATE: Nonsense: CREST Does Not Justify Increased Usage Of CAS For Symptomatic And Asymptomatic Carotid Stenosis |
| Presenter(s):Michel Makaroun, MD | |
| 2:30 PM - 2:35 PM | What Is The Real Meaning Of Minor Strokes As Defined In CREST: Do They Matter More Than A Minor MI |
| Presenter(s):Emmanuel M. Houdart, MD | |
| 2:36 PM - 2:41 PM | DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CEA Is Best And Does Not Increase Procedural Risk |
| Presenter(s):A. Ross Naylor, MD, FRCS | |
| 2:42 PM - 2:47 PM | DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CAS Is Best And Can Be Done Safely |
| Presenter(s):Barry T. Katzen, MD | |
| 2:48 PM - 2:53 PM | What Is The Best Current Treatment For Recently Symptomatic Carotid Stenosis: CAS Or CEA: Based On Combined Data From RCTs |
| Presenter(s):Gustav Fraedrich, MD | |
| ASYMPTOMATIC CAROTID STENOSIS | |
| 2:54 PM - 2:59 PM | DEBATE: Few If Any Patients Benefit From CEA Or CAS For Asymptomatic Carotid Stenosis In The Properly Used Statin Era |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| 3:00 PM - 3:05 PM | DEBATE: Not So! Many Asymptomatic Carotid Stenosis Patients Benefit From CAS And CEA: Which Ones |
| Presenter(s):Peter A. Schneider, MD | |
| View Abstract | |
| 3:06 PM - 3:11 PM | Asymptomatic Carotid Stenosis Can Progress And Become Symptomatic In A Substantial Proportion Of Patients |
| Presenter(s):Richard P. Cambria, MD / Glenn M. LaMuraglia, MD / Mark Conrad, MD | |
| 3:12 PM - 3:17 PM | New Insights Into Selecting Asymptomatic Carotid Stenosis Patients At High Stroke Risk Who Should Have CAS Or CEA: The Importance Of Juxtaluminal Black Areas (JBAs) |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
| View Abstract | |
| 3:18 PM - 3:23 PM | How To Pick High Risk Asymptomatic Carotid Stenosis Patients For CAS Or CEA: The Importance Of Transcranial Doppler Hits |
| Presenter(s):J. David Spence, MD | |
| View Abstract | |
| 3:24 PM - 3:29 PM | How To Pick Asymptomatic Carotid Stenosis Patients For CAS: What Percentage Of All Asymptomatic High Grade Lesions Should Be Treated |
| Presenter(s):Sriram S. Iyer, MD | |
| 3:30 PM - 3:40 PM | Panel Discussion |
| 3:40 PM - 4:00 PM | Break - 40th Anniversary Celebration (Cocktails Will Be Served)Rhinelander Gallery (2nd Floor) |
| END OF SESSION 26 | |
| SESSION 27 SCHEDULE | |
|
Wednesday
SESSION 27:
NEW INFORMATION ON RENAL DENERVATION AND INTERVENTIONAL
Moderators:Bruce A. Perler, MD, MBA / Frank J. Veith, MD
|
|
| x | |
| RENAL DENERVATION | |
| 4:00 PM - 4:05 PM | How Does Sympathetic Denervation By Endovascular Renal Artery Radiofrequency Ablation Work |
| Presenter(s):John W. Osborn, PhD | |
| View Abstract | |
| 4:06 PM - 4:11 PM | What Does Renal Denervation Do For Drug Resistant Hypertension And Other Conditions: Diabetes, Heart Disease And Arrhythmias |
| Presenter(s):Michael R. Jaff, DO | |
| 4:12 PM - 4:17 PM | Innovative Approaches To Renal Denervation: What Are The Old And New Devices: Are There Differences |
| Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD | |
| 4:18 PM - 4:23 PM | What Is The Target In Renal Denervation: Why Is The Artery Not Damaged Or Is It |
| Presenter(s):Renu Virmani, MD | |
| 4:24 PM - 4:29 PM | Surgical Denervation Of The Renal Arteries Treats Resistant Hypertension Effectively: Surgeons Should Perform Renal Denervation Procedures – Endovascular And Open |
| Presenter(s):Juan C. Parodi, MD | |
| 4:30 PM - 4:35 PM | Panel Discussion |
| THE CCSVI AND MS CONTROVERSY | |
| Moderator(s): L. Nelson Hopkins, MD / Frank J. Veith, MD | |
| 4:35 PM - 4:40 PM | What New Information Supports The Effectiveness Of Treating CCSVI In MS Patients |
| Presenter(s):Paolo Zamboni, MD / Francesco Mascoli, MD | |
| 4:41 PM - 4:46 PM | CCSVI Treatment Helps Some MS Patients: What We Know And What We Do Not Know: Is A Randomized Trial In The Works |
| Presenter(s):Michael D. Dake, MD | |
| 4:47 PM - 4:52 PM | What Is The Evidence That Balloon Venoplasty Is Effective Treatment In Patients With CCSVI And MS |
| Presenter(s):Donald B. Reid, MD | |
| 4:53 PM - 4:58 PM | DEBATE: Clinical Experience Supports The Value Of Venous Balloon Angioplasty For Many MS Patients: RCTs Will Be Impossible |
| Presenter(s):Ivo Petrov, MD, PhD | |
| 4:59 PM - 5:04 PM | DEBATE: Skepticism Is Healthy In This Area: The Evidence To Date Is Weak And Unconvincing |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| 5:05 PM - 5:10 PM | Venous Balloon Angioplasty For MS Makes No Sense: Any Benefit Is Due To A Placebo Effect And The Nature Of The Disease |
| Presenter(s):Emmanuel M. Houdart, MD | |
| 5:11 PM - 5:16 PM | Another Negative View On The Value Of Interventional Treatment For MS: The Supporting Evidence Is Too Weak |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD / Jim Reekers, MD, PhD | |
| 5:17 PM - 5:22 PM | Does Venous Balloon Angioplasty Help Patients With CSVI: Early Results Of A RCT Cast Doubt: When Will We Know |
| Presenter(s):Robert Zivadinov, MD, PhD, FAAN | |
| View Abstract | |
| 5:23 PM - 5:28 PM | Panel Discussion |
| END OF SESSION 27 | |
| SESSION 28 SCHEDULE | |
|
Wednesday
SESSION 28:
MORE CAROTID TOPICS
Moderators:Daniel G. Clair, MD / Jean-Baptiste Ricco, MD, PhD
|
|
| x | |
| 5:28 PM - 5:33 PM | Asymptomatic Lesions In Diffusion Weighted (DW) And Flair MRI: What Are The Real Implications |
| Presenter(s):Jörn O. Balzer, MD, PhD | |
| 5:34 PM - 5:39 PM | Management Of Complications During And After CAS: How Important Is It And Tips And Tricks For Doing It |
| Presenter(s):Klaus D. Mathias, MD | |
| 5:40 PM - 5:45 PM | Reversal Of A Longstanding Major Neurological Deficit By Improving Carotid Flow With CAS |
| Presenter(s):Robert M. Bersin, MD | |
| 5:46 PM - 5:51 PM | Emergency CEA For Patients With Stroke In Evolution: When Is It Indicated And How Should It Be Performed |
| Presenter(s):Hans-Henning Eckstein, MD, PhD | |
| 5:52 PM - 5:57 PM | How Can Computerized Duplex Ultrasound Identify Unstable Risky Plaques In Asymptomatic Carotid Stenosis Patients |
| Presenter(s):A. Ross Naylor, MD, FRCS | |
| 5:58 PM - 6:03 PM | What Is Current Best Medical Therapy: What Does It Do To Carotid Plaques And Do Patients Accept It And Comply With It |
| Presenter(s):J. David Spence, MD | |
| View Abstract | |
| 6:04 PM - 6:09 PM | How Bad And Persistent Were The Cranial Nerve Deficits In CREST |
| Presenter(s):Robert J. Hye, MD / Ariane Mackey, MD / Thomas G. Brott, MD | |
| 6:10 PM - 6:15 PM | For Radiation Induced Symptomatic Carotid Stenosis, What Is The Best Treatment: CAS Or CEA |
| Presenter(s):Frans L. Moll, MD, PhD | |
| 6:16 PM - 6:25 PM | Panel Discussion End of Program A |
| END OF SESSION 28 | |
| SESSION 29 SCHEDULE | |
|
Wednesday
SESSION 29:
LOWER EXTREMITY OCCLUSIVE DISEASE – HOT TOPICS I
Moderators:Enrico Ascher, MD / Keith D. Calligaro, MD
|
|
| x | |
| 6:50 AM - 6:54 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| 6:54 AM - 6:59 AM | Status Of Tibial Interventions In The US: Role Of Balloons, Bare Metal Stents (BMS) And Drug Eluting Stents (DES) |
| Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
| 7:00 AM - 7:05 AM | In The US, For CLI Endovascular First Is Not Cost Effective And For Long SFA Lesions Open Bypass Is Best |
| Presenter(s):Firas F. Mussa, MD | |
| 7:06 AM - 7:11 AM | New Recent Advances And Adjuncts To Prevent Radiocontrast Nephropathy After Endovascular Treatments Under Fluoroscopic Guidance |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Abstract | |
| 7:12 AM - 7:17 AM | Efficacy Of Atherectomy And Drug Eluting Balloons (DEBs): Where Is This Best: Based On The DEFINITIVE AR Trial |
| Presenter(s):Gunnar Tepe, MD | |
| 7:18 AM - 7:23 AM | New Techniques For Below-The-Knee (BTK) Endo Procedures Including The OFFROAD Device To Facilitate Re-Entry After Subintimal Wire Passage |
| Presenter(s):Andrej Schmidt, MD | |
| 7:24 AM - 7:29 AM | Less Invasive Interventions With 4 French Systems Like The Astron Pulsar Stent: The 4 EVER Trial Final Results: Closure Devices Are Not Needed |
| Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
| 7:30 AM - 7:35 AM | DEBATE: For BTK Occlusive Lesions Subintimal Wire Passage Works And Is Best |
| Presenter(s):Amman Bolia, MD | |
| View Abstract | |
| 7:36 AM - 7:41 AM | DEBATE: For BTK Occlusive Lesions Subintimal Wire Passage Has Pros And Cons |
| Presenter(s):Roberto Ferraresi, MD | |
| 7:42 AM - 7:47 AM | Interventions In The Pedal Arch: When And How, Including Retrograde Digital Artery Puncture: Limitations And Results |
| Presenter(s):Mariano Palena, MD / Marco G. Manzi, MD | |
| 7:48 AM - 7:53 AM | How To Make Transtibial And Transpedal Access Work In The US |
| Presenter(s):Brian G. DeRubertis, MD | |
| 7:54 AM - 7:59 AM | Panel Discussion |
| END OF SESSION 29 | |
| SESSION 30 SCHEDULE | |
|
Wednesday
SESSION 30:
LOWER EXTREMITY OCCLUSIVE DISEASE – HOT TOPICS II
Moderators:Mark H. Wholey, MD / Joseph L. Mills, MD
|
|
| x | |
| 8:00 AM - 8:05 AM | DEBATE: With CLI, Bypasses Are Never Indicated First: Are They Ever Needed |
| Presenter(s):Craig M. Walker, MD | |
| 8:06 AM - 8:11 AM | DEBATE: There Are CLI Patients Who Cannot Or Should Not Be Treated Endovascularly: Who Are They |
| Presenter(s):George H. Meier III, MD | |
| 8:12 AM - 8:17 AM | There Is A Major Role For Open Distal Bypass Operations To Salvage CLI Limbs After Failed Endovascular Interventions |
| Presenter(s):Frank B. Pomposelli, MD | |
| 8:18 AM - 8:23 AM | Value And Effectiveness Of The In.Pact Drug Eluting Balloon (DEB) In Treating BTK Arteries For CLI |
| Presenter(s):Andrej Schmidt, MD | |
| 8:24 AM - 8:29 AM | DEBATE: DEBs And DESs (Zilver PTX) Are Equally Good For Long Fem-Pop Lesions But DES Are Better For Long Infrapopliteal Lesions |
| Presenter(s):Thomas Zeller, MD | |
| 8:30 AM - 8:35 AM | DEBATE: DEBs Are As Good As DES: How To Choose Based On Lesion Length, Location, Etc: Results Of The REAL Trial |
| Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
| 8:36 AM - 8:41 AM | Value Of DEBs (Paclitaxil) vs. Uncoated Balloons After SFA Nitinol Stenting – The FREEWAY Multicenter RCT: What Are The Cost Implications |
| Presenter(s):Stefan Mueller-Huelsbeck, MD | |
| View Abstract | |
| 8:42 AM - 8:47 AM | Plain Old Balloon Angioplasty (POBA) Is Best For CLI For Infrapopliteal Disease: Do It Right And Don’t Replace It With Other Techniques Like DEBs Or DESs Which May Be Unsuitable And More Costly |
| Presenter(s):Iris Baumgartner, MD | |
| 8:48 AM - 8:53 AM | Are There Negative Consequences To Extreme Or Overly Persistent Endovascular Treatments For CLI |
| Presenter(s):Francesco Spinelli, MD | |
| View Abstract | |
| 8:54 AM - 9:00 AM | Panel Discussion |
| END OF SESSION 30 | |
| SESSION 31 SCHEDULE | |
|
Wednesday
SESSION 31:
LOWER EXTREMITY OCCLUSIVE DISEASE - HOT TOPICS III
Moderators:Giancarlo Biamino, MD, PhD / Michael S. Conte, MD
|
|
| x | |
| 9:00 AM - 9:05 AM | Long-Term Results With Drug Eluting Balloons (DEBs) Are Favorable And Show That DEBs Can Eliminate The Need For Stents – Even When PTA Causes Substantial Dissection |
| Presenter(s):Gunnar Tepe, MD | |
| 9:06 AM - 9:11 AM | Final Results Of The DEBATE Randomized Trials (BK And SFA) Of DEBs In Diabetics With CLI: DEBs Are Effective But Are All DEBs Equal |
| Presenter(s):Francesco Liistro, MD | |
| 9:12 AM - 9:17 AM | Extreme Below-The-Knee (BTK) Interventions: When To Dare And When To Stop: What Techniques Help |
| Presenter(s):Mariano Palena, MD / Marco G. Manzi, MD | |
| 9:18 AM - 9:23 AM | In Lower Limb Ischemia Patients The Presenting Symptom Makes A Difference: Patients With Claudication, Rest Pain And Major Gangrene Should Be Managed Differently |
| Presenter(s):Roberto Ferraresi, MD | |
| 9:24 AM - 9:29 AM | New Tools And Tricks For Treating Tibial CTOs Including Transcollateral Crossing Of Total Occlusions |
| Presenter(s):Craig M. Walker, MD | |
| 9:30 AM - 9:35 AM | Long-Term Results Of The SUPERA Stent For Femoral And Popliteal Lesions: Advantages And Limitations |
| Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
| 9:36 AM - 9:41 AM | DEBATE: DESs Will Be The New Gold Standard For Treating Difficult SFA Lesions |
| Presenter(s):Gary M. Ansel, MD | |
| 9:42 AM - 9:47 AM | DEBATE: Not True: DEBs Will Be The Gold Standard For Treating SFA Lesions |
| Presenter(s):Giancarlo Biamino, MD, PhD | |
| 9:48 AM - 9:53 AM | Failed SFA Endovascular Interventions For Advanced Infrainguinal Disease Have An Important Negative Impact On Limb Salvage |
| Presenter(s):Ross Milner, MD | |
| 9:54 AM - 10:00 AM | Panel Discussion And Break |
| END OF SESSION 31 | |
| SESSION 32 SCHEDULE | |
|
Wednesday
SESSION 32:
NEW DEVELOPMENTS IN TREATING CRITICAL LOWER EXTREMITY ISCHEMIA (CLI) IN STENT RESTENOSIS (ISR), ATHERECTOMY AND MORE ON DESs
Moderators:Barry T. Katzen, MD / Frank J. Veith, MD
|
|
| x | |
| 10:00 AM - 10:05 AM | DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: An Interventionalist’s View |
| Presenter(s):Thomas Zeller, MD | |
| 10:06 AM - 10:11 AM | DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: A Surgeon’s View |
| Presenter(s):Frank E.G. Vermassen, MD, PhD | |
| 10:12 AM - 10:17 AM | Pedal Bypass With Deep Vein Arterialization Is Especially Applicable In Certain Specific Critical Ischemic Situations: Late Results |
| Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
| View Abstract | |
| IN STENT RESTENOSIS (ISR) | |
| 10:18 AM - 10:23 AM | Insights Into The Pathogenesis Of ISR |
| Presenter(s):Renu Virmani, MD | |
| 10:24 AM - 10:29 AM | DEBATE: DEBs Are The Best Treatment For ISR |
| Presenter(s):Francesco Liistro, MD | |
| 10:30 AM - 10:35 AM | DEBATE: Covered Stents (Viabahn) Are The Best Treatment For ISR: Based On The RELINE Randomized Controlled Trial Comparing Them To Balloon PTA |
| Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
| 10:36 AM - 10:41 AM | DEBATE: Atherectomy Or Laser And DEBs Are The Best Treatment For ISR: Good Results Are Durable |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| 10:42 AM - 10:47 AM | Optimal Treatment Of ISR: A US Perspective |
| Presenter(s):Craig M. Walker, MD | |
| ATHERECTOMY | |
| 10:48 AM - 10:53 AM | DEBATE: Atherectomy Will Not Become First Line Treatment Even Though The New Devices Are Better Than The Old |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| 10:54 AM - 10:59 AM | DEBATE: Atherectomy Is Effective And Durable Treatment For Lower Extremity Occlusive Disease: Which Device Is Best |
| Presenter(s):James F. McKinsey, MD | |
| 11:00 AM - 11:05 AM | Atherectomy Has Value In Association With DEBs For Fem-Pop Lesions: What Is The Value Of Cilostazol In Preventing Restenosis |
| Presenter(s):Thomas Zeller, MD | |
| 11:06 AM - 11:11 AM | What Is The Future For Atherectomy After Past Failures And Conflicting Data |
| Presenter(s):Sean P. Lyden, MD | |
| 11:12 AM - 11:17 AM | Atherectomy Is Of Little Value For Tibial Lesions |
| Presenter(s):Jean M. Panneton, MD | |
| MORE ON DRUG ELUTING STENTS (DES) ETC. | |
| 11:18 AM - 11:23 AM | DEBATE: New Findings From The ZILVER PTX Trial: Are The Benefits Of This DES Durable: Do The Good Results (3 Years And Beyond) Justify The Costs |
| Presenter(s):Michael D. Dake, MD | |
| 11:24 AM - 11:29 AM | DEBATE: DEBs And Latest Generation Bare Metal Stents (BMS): Do They Obviate The Need For DESs |
| Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
| 11:30 AM - 11:35 AM | What I Learned From European Vascular Specialists About Treating BTK Lesions |
| Presenter(s):Peter A. Schneider, MD | |
| 11:36 AM - 11:41 AM | Overview Of The Newer And Old CTO Crossing Devices: What Are They And When Are They Useful |
| Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
| 11:42 AM - 11:47 AM | Decreasing Access Site Complications With Routine Ultrasound Guidance And Micropuncture Technique |
| Presenter(s):Peter A. Schneider, MD | |
| View Abstract | |
| 11:48 AM - 11:59 AM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 32 | |
| SESSION 33 SCHEDULE | |
|
Wednesday
SESSION 33:
MORE INTERESTING TOPICS RELATED TO LOWER EXTREMITY VASCULAR DISEASE
Moderators:Lindsay Machan, MD / Albrecht H. Kramer, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Biodegradable DESs To Treat Iliac And Femoral Lesions: Are They Promising: Results From The ESPRIT Trial |
| Presenter(s):Johannes Lammer, MD | |
| 1:06 PM - 1:11 PM | Results Of A Bioabsorbable REMEDY Stent To Treat SFA Disease: Advantages And Limitations |
| Presenter(s):Peter C.J. Goverde, MD / Frank E.G. Vermassen, MD, PhD | |
| 1:12 PM - 1:17 PM | How To Deal With Complex CTOs In Tortuous Anatomy: Best Guidewire Selection And Step-By-Step Technique For Retrograde Fem-Pop Access And Recanalization Via Tibial Punctures |
| Presenter(s):Andrej Schmidt, MD | |
| 1:18 PM - 1:23 PM | Which Is Worse For Diseased Arteries: Metal (Stents) Or Toxic Drugs (On DEBs And DESs): What Will The Long-Term Effects Be |
| Presenter(s):Renu Virmani, MD | |
| 1:24 PM - 1:29 PM | DEBs: How Well Do They Really Work For SFA And BTK Lesions: Based On RCTs And Real World Data: Does Debulking Help |
| Presenter(s):Giancarlo Biamino, MD, PhD | |
| 1:30 PM - 1:35 PM | Tack Optimized Plain Balloon Angioplasty: Will It Replace Stenting-The-Tack-It Device: How Does It Work And The TOBA Trial |
| Presenter(s):Koen Deloose, MD | |
| 1:36 PM - 1:41 PM | Can OCT (Optical Coherence Tomography) Be Used To Help Decide When A Post PTA Dissection Needs To Be Fixed With A Tack-It Device Or Stent |
| Presenter(s):Marianne Brodmann, MD | |
| 1:42 PM - 1:47 PM | Pedal Access And Pedal Loop Interventions: When Should They Be Done And How Durable Are They |
| Presenter(s):Roberto Ferraresi, MD | |
| 1:48 PM - 1:53 PM | Tibial Artery Endovascular Treatments In The US Are Not Durable: Will New Technology Change That |
| Presenter(s):Rabih A. Chaer, MD | |
| 1:54 PM - 1:59 PM | DEBATE: When Should CLI Patients Be Treated With A Bypass: An Endovascularly Oriented Surgeon’s View |
| Presenter(s):Koen Deloose, MD | |
| 2:00 PM - 2:05 PM | DEBATE: When Should CLI Patients Be Treated By A Bypass: An Interventionalist’s View |
| Presenter(s):Gary M. Ansel, MD | |
| 2:06 PM - 2:11 PM | Why Open Surgery Is An Important Part Of Limb Salvage With CLI: Will We Ever Have A Novel Prospective Multicenter Registry Comparing Bypass Surgery To Modern Endovascular Treatment |
| Presenter(s):Nobuyoshi Azuma, MD / Osamu Iida, MD | |
| 2:12 PM - 2:19 PM | Panel Discussion |
| END OF SESSION 33 | |
| SESSION 34 SCHEDULE | |
|
Wednesday
SESSION 34:
NEW INFORMATION ABOUT STENT-GRAFTS ESPECIALLY IN THE LOWER
Moderators:Gary Giangola, MD / Dennis R. Gable, MD, FACS
|
|
| x | |
| 2:20 PM - 2:25 PM | New Concepts About Biodegradable Stent-Grafts And Stents |
| Presenter(s):Timur P. Sarac, MD | |
| 2:26 PM - 2:31 PM | Role Of Covered Stents To Treat Obesity By Modulating Visceral Blood Flow |
| Presenter(s):Timothy P. Murphy, MD | |
| 2:32 PM - 2:37 PM | Stent-Grafts vs. Bare Metal Stents For SFA Disease: Lessons Learned From The VIPER And VIASTAR Trials: When Are Stent-Grafts Better |
| Presenter(s):Johannes Lammer, MD | |
| 2:38 PM - 2:43 PM | Top 10 Technical Considerations To Maximize Outcomes Of Viabahn Stent-Grafts In The SFA |
| Presenter(s):Michael B. Silva, Jr., MD | |
| 2:44 PM - 2:49 PM | Technical Steps To Performing Aorto-Iliac Stent-Grafting With Balloon Expandable Stent Grafts (Atrium) For Distal Aortic And Iliac Disease And When The Aortic Occlusion Is Juxtarenal: The CERAB Technique For Protecting The Renal Arteries |
| Presenter(s):Peter C.J. Goverde, MD / Michel M.P. Reijnen, MD, PhD | |
| 2:50 PM - 2:55 PM | DEBATE: Advantages To Balloon Expandable Stent-Grafts (Atrium) For Aorto-Iliac Occlusive Disease: Why Is It Better Than Stenting And Open Surgery |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
| View Abstract | |
| 2:56 PM - 3:01 PM | DEBATE: Open Surgical Repair For Juxtarenal Aortic Occlusive Disease Is Simpler, Safer And Better Than Endovascular Approaches: Technical Tips |
| Presenter(s):Roberto Chiesa, MD | |
| View Abstract | |
| 3:02 PM - 3:07 PM | Stent-Graft And Stent Treatment Of Juxtarenal Aortic Occlusions: How Can It Be Done Safely, What Are The Pitfalls And How Durable Is It |
| Presenter(s):Martin Malina, MD, PhD | |
| 3:08 PM - 3:15 PM | Panel Discussion |
| 3:15 PM - 3:45 PM | Break - 40th Anniversary Celebration (Cocktails Will Be Served)Rhinelander Gallery (2nd Floor) |
| END OF SESSION 34 | |
| SESSION 35 SCHEDULE | |
|
Wednesday
SESSION 35:
MORE LOWER EXTREMITY AND RELATED HOT TOPICS
Moderators:Mark A. Adelman, MD / Peter F. Lawrence, MD
|
|
| x | |
| 3:45 PM - 3:50 PM | Ultrasound Is A New And Critical Adjunct In The Diagnosis And Treatment Of Popliteal Entrapment Syndromes |
| Presenter(s):Niten Singh, MD | |
| 3:51 PM - 3:56 PM | Where Is The Solid Data To Show That Outcomes Of Endovascular Lower Extremity Interventions Are Better Than Open Surgery |
| Presenter(s):Scott L. Stevens, MD | |
| 3:57 PM - 4:02 PM | Blue Toe Syndrome – An Under-Recognized Entity: Tips And Current Advances In Diagnosis And Treatment |
| Presenter(s):Afshin Assadian, MD | |
| 4:03 PM - 4:08 PM | Unusual Causes Of Blue Toe Syndrome That Are Treatable By Thrombolysis |
| Presenter(s):Thomas O. McNamara, MD | |
| 4:09 PM - 4:14 PM | Atherectomy For Calcified Lesions: Which Device Works Best For Which Lesions |
| Presenter(s):Lawrence A. Garcia, MD | |
| 4:15 PM - 4:20 PM | Retrograde Popliteal Access Is Safe And Effective: When And How To Do It |
| Presenter(s):Mark G. Davies, MD | |
| 4:21 PM - 4:26 PM | New Findings From The ZILVER PTX Trial After 3 Years Of Observation: Do DESs Work As Well In Diabetics, For In Stent Restenosis And TASC C And D Lesions As For Standard Patients And Lesions |
| Presenter(s):Michael D. Dake, MD | |
| 4:27 PM - 4:32 PM | Does Zilver PTX Drug Eluting Stenting Yield Better Results Than An Open Bypass |
| Presenter(s):Marc Bosiers, MD | |
| 4:33 PM - 4:38 PM | Early Patency Results Of A Multicenter RCT Comparing In.Pact DEBs With Uncoated Balloons In SFA, Popliteal And BTK Lesions |
| Presenter(s):Erik E. Debing, MD, PhD | |
| 4:39 PM - 4:44 PM | For Popliteal Lesions Is Stenting Better Than PTA: The ETAP Trial 1-Year Results |
| Presenter(s):Thomas Zeller, MD | |
| 4:45 PM - 4:51 PM | Panel Discussion |
| END OF SESSION 35 | |
| SESSION 36 SCHEDULE | |
|
Wednesday
SESSION 36:
UPDATE ON NEW INFORMATION ABOUT ENDOLEAKS AND THEIR MANAGEMENT
Moderators:Alan B. Lumsden, MD, FACS / Claudio J. Schonholz, MD
|
|
| x | |
| 4:51 PM - 4:56 PM | Recurrent Endoleaks: How Should They Be Treated And How Successful Is The Treatment |
| Presenter(s):Götz M. Richter, MD, PhD | |
| 4:57 PM - 5:02 AM | Many (> 1/3) Patients With Unstable AAA Sacs And “Endotension” After EVAR Really Have Positional-Dependent Endoleaks: How To Diagnose And Treat This Problem |
| Presenter(s):James May, MD, MS, FRACS, FACS | |
| View Abstract | |
| 5:03 PM - 5:08 PM | Is Perigraft Hygroma Without Endoleak A Real Cause Of Endotension And Sac Enlargement: How Should It Be Treated |
| Presenter(s):John Blebea, MD, MBA | |
| 5:09 PM - 5:14 PM | Defining Endotension: An Experimental Model Explaining Why It is Really An Unrecognized Type I Endoleak |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
| 5:15 PM - 5:20 AM | Translumbar Glue Embolization For Type II Endoleaks: Guidance With 3D Imaging Using Siemens Software And The Zeego System Make This Safer, More Reliable And Quicker |
| Presenter(s):Neal S. Cayne, MD | |
| 5:21 PM - 5:26 PM | Trans IVC Approach To Treat Type II Endoleaks: When And How |
| Presenter(s):Patrice F. Bergeron, MD | |
| 5:27 PM - 5:32 PM | Chronic Type II Endoleaks Contribute To Late Endograft Fixation Failures After EVAR And Should Be Fixed |
| Presenter(s):Martin R. Back, MD | |
| 5:33 PM - 5:38 PM | What Is The Best Way To Treat Type II Endoleaks: Aggressive vs. Conservative, Route Of Treatment And Agent |
| Presenter(s):Robert A. Morgan, MD | |
| 5:39 PM - 5:44 PM | Partial Conversion With Endograft Salvage For Endotension And Persistent Type II Endoleak After EVAR: When And How To Use This Simpler Way |
| Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD | |
| View Abstract | |
| 5:45 PM - 5:50 PM | DEBATE: Most Type II Endoleaks After EVAR Are Benign: For The Motion |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| 5:51 PM - 5:56 PM | DEBATE: Most Type II Endoleaks After EVAR Are Benign: Against The Motion |
| Presenter(s):Frans L. Moll, MD, PhD | |
| 5:57 PM - 6:02 PM | Most Type II Endoleaks After EVAR Should Be Taken Seriously |
| Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
| 6:03 PM - 6:08 PM | Laser-Assisted Transarterial Endograft Puncture Into The AAA Sac For Type 2 Endoleak Treatment With Onyx: A New Approach: Technique And Results |
| Presenter(s):Mark W. Mewissen, MD | |
| 6:09 PM - 6:20 PM | Panel Discussion End of Program B |
| END OF SESSION 36 | |
| SESSION 37 SCHEDULE | |
|
Wednesday
SESSION 37:
NEW DEVELOPMENTS IN VENOUS DISEASE: TREATMENT OF LARGE VEIN DISEASE AND HOT TOPICS ON IVC FILTERS
Moderators:Plinio Rossi, MD / Lowell S. Kabnick, MD, FACS, FACPh
|
|
| x | |
| 7:10 AM - 7:14 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| 7:15 AM - 7:20 AM | Improved Treatment Of Klippel-Trenaunay Syndrome With Steam Venous Sclerosis And Foam |
| Presenter(s):Samy S. Nitecki, MD | |
| View Abstract | |
| 7:21 AM - 7:26 AM | Avoiding Pitfalls Of The Nutcracker Syndrome: Is Stenting Of The Left Renal Vein The Best Treatment |
| Presenter(s):J. Leonel Villavicencio, MD | |
| View Abstract | |
| 7:27 AM - 7:32 AM | DEBATE: Embolization Has A Major Role In Treatment Of Varicocele And Pelvic Congestion Syndrome |
| Presenter(s):Lindsay Machan, MD | |
| View Abstract | |
| 7:33 AM - 7:38 AM | DEBATE: Left Renal Vein Stenting Is The Best Treatment For The Nutcracker Syndrome And Pelvic Congestion |
| Presenter(s):Michael D. Dake, MD | |
| 7:39 AM - 7:44 AM | Should You Worry About The Left Renal Vein When Occluding The Left Ovarian Vein |
| Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
| 7:45 AM - 7:52 AM | Panel Discussion |
| IVC FILTER RELATED TOPICS | |
| Moderator(s): Fedor Lurie, MD, PhD / Seshadri Raju, MD | |
| 7:53 AM - 7:58 AM | GI Complications Of IVC Filters And Endovascular Treatment Of Filters With GI Tract Complications |
| Presenter(s):Rabih A. Chaer, MD | |
| 7:59 AM - 8:04 AM | Tips And Tricks To Help Remove IVC Filters (Retrievable And Permanent) That Resist Removal |
| Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD | |
| 8:05 AM - 8:10 AM | Update On The Sentry Bioconvertible Non-Retrieval IVC Filter: Early Clinical Results And Why It Is A New Horizon |
| Presenter(s):David Rosenthal, MD / Albrecht H. Kramer, MD | |
| View Abstract | |
| 8:11 AM - 8:16 AM | Major Complications After IVC Filter Placement And How To Avoid Them |
| Presenter(s):Clifford M. Sales, MD, MBA | |
| View Abstract | |
| 8:17 AM - 8:22 AM | Symptomatic Duodenal Perforation By IVC Filters: Incidence, Prevention And Treatment |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| 8:23 AM - 8:28 AM | Why Are Retrievable IVC Filters Hard To Remove: Tips And Tricks To Do It |
| Presenter(s):Brian G. DeRubertis, MD | |
| 8:29 AM - 8:34 AM | Prolonged Radiation Exposure During IVC Filter Removal And How To Avoid It |
| Presenter(s):Mark D. Iafrati, MD | |
| 8:35 AM - 8:40 AM | Which Patients Should Have A Prophylactic IVC Filter Placed During Catheter Based Treatment Of Large Vein Clots: Based On A RCT – The Filter PEVI Study |
| Presenter(s):Mohsen Sharifi, MD | |
| View Abstract | |
| 8:41 AM - 8:46 AM | Correlation Of IVUS And CT Scan Measurements For Placement Of IVUS-Guided IVC Filters |
| Presenter(s):David L. Gillespie, MD | |
| 8:47 AM - 8:52 AM | IVC Filter Usage In The US: Do The Benefits Outweigh The Risks And How Should Filter Removal Decrease The Risks While Preserving The Benefits |
| Presenter(s):J. Pablo Morales, MD / Kenneth J. Cavanaugh, Jr., PhD | |
| 8:53 AM - 9:02 AM | Panel Discussion |
| END OF SESSION 37 | |
| SESSION 38 SCHEDULE | |
|
Wednesday
SESSION 38:
VENOUS HOT TOPICS RELATED TO CHRONIC OCCLUSIVE DISEASE, POST-PHLEBITIC SYNDROME AND VENOUS STENTS
Moderators:Mark H. Meissner, MD / Jose I. Almeida, MD, RVT, FACS
|
|
| x | |
| 9:03 AM - 9:08 AM | Best Medical Management Of Post-Thrombotic Syndrome: How Good Or Bad Is It |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| 9:09 AM - 9:14 AM | Can The Post-Thrombotic Syndrome Be Avoided |
| Presenter(s):Bo G. Eklof, MD, PhD | |
| View Abstract | |
| 9:15 AM - 9:20 AM | Deep Venous Stenting: Which Patients Need It, How Can One Tell, What Is The Benefit |
| Presenter(s):Todd Berland, MD / Lowell S. Kabnick, MD, FACS, FACPh | |
| 9:21 AM - 9:26 AM | Ballooning And Stenting Are Not Enough For Iliac Vein Obstruction And Reflux: What Else Must Be Done |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Abstract | |
| 9:27 AM - 9:32 AM | Long-Term Outcomes Of May-Thurner Syndrome Treatment |
| Presenter(s):Rabih A. Chaer, MD | |
| 9:33 AM - 9:38 AM | With Venous Stents In The IVC And Iliac Veins, Do Late Problems Develop Or Do They Provide An Effective Durable Treatment |
| Presenter(s):Seshadri Raju, MD | |
| 9:39 AM - 9:45 AM | Can Venous Stents Safely Be Placed Across The Junction Of The Common Iliac Veins And The IVC: Will It Cause Thrombosis And Problems |
| Presenter(s):David L. Gillespie, MD | |
| 9:46 AM - 9:51 AM | Bilateral Iliac Vein Stenting: Improving The Raju-Neglen Fenestration Technique |
| Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
| 9:52 AM - 9:57 AM | Venous Stents Below The Inguinal Ligament, Through Occluded IVC Filters And Into The Profunda Vein: Technique And Results |
| Presenter(s):Seshadri Raju, MD | |
| 9:58 AM - 10:08 AM | Panel Discussion |
| 10:09 AM - 10:40 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 38 | |
| SESSION 39 SCHEDULE | |
|
Wednesday
SESSION 39:
TREATMENT OF ACUTE AND SUBACUTE LARGE VEIN THROMBOSIS AND OTHER NEW DEVELOPMENTS IN VENOUS DISEASE
Moderators:Bo G. Eklof, MD, PhD / Peter Gloviczki, MD
|
|
| x | |
| 10:40 AM - 10:45 AM | When Is Open Thrombectomy Or Other Open Surgical Treatment Best For The Post-Thrombotic Syndrome |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| 10:46 AM - 10:51 AM | Optimal Strategy For Treatment Of Symptomatic Iliofemoral DVT With Lysis, Mechanical Clot Removal And What Else |
| Presenter(s):Mark W. Mewissen, MD | |
| 10:52 AM - 10:57 AM | Overview Of Current Role Of Lysis, Mechanical Thrombectomy And Stents For Acute And Subacute Iliofemoral And Caval DVT: What Is The Evidence In Support |
| Presenter(s):Mark H. Meissner, MD | |
| 10:58 AM - 11:03 AM | Free Floating Thrombus In The IVC Or Iliac Veins: What Is The Risk And How Should It Be Treated |
| Presenter(s):Michael C. Dalsing, MD | |
| View Abstract | |
| 11:04 AM - 11:09 AM | Successful Treatment Of Acute Or Subacute Venous Obstructive Disease With The Rotarex/Aspirex Device |
| Presenter(s):Andrej Schmidt, MD | |
| 11:10 AM - 11:15 AM | Are Oral Factor 10 And 2 Inhibitors (Rivaroxaban, Apixaban, Dabigatran) Here To Stay Or Not: Advantages And Limitations |
| Presenter(s):Bauer E. Sumpio, MD, PhD | |
| 11:16 AM - 11:21 AM | How To Use Coumadin And Newer Antithrombotic Agents After An Intervention; After Open Non-Vascular And Vascular Surgery |
| Presenter(s):Fedor Lurie, MD, PhD | |
| 11:22 AM - 11:27 AM | Genetic And Other Factors Promoting DVT: How Can They Be Detected And Treated |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Abstract | |
| 11:28 AM - 11:33 AM | Aspirin Therapy For Recurrent Venous Thromboprophylaxis Has Now Been Proven Effective |
| Presenter(s):Mark H. Meissner, MD | |
| 11:34 AM - 11:39 AM | Percutaneous Foam Sclerotherapy For Venous Ulcers |
| Presenter(s):Ronald G. Bush, MD / Peggy Bush, MSN, APN | |
| 11:40 AM - 11:50 AM | Panel Discussion |
| 11:50 AM - 1:00 PM | Lunch Break - Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 39 | |
| SESSION 40 SCHEDULE | |
|
Wednesday
SESSION 40:
OTHER NEW DEVELOPMENTS IN THE MANAGEMENT OF VENOUS DISEASE
Moderators:William A. Marston, MD / Thomas W. Wakefield, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Tips And Tricks For Improving Treatment Of Venous Ulcers |
| Presenter(s):Albeir Y. Mousa, MD | |
| 1:06 PM - 1:11 PM | SVS/AVF Guidelines For Venous Ulcer Management: How Can Costs Be Minimized |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Abstract | |
| 1:12 PM - 1:17 PM | A Workable Plan For The Endovenous Treatment Of Leg Ulcers: How Effective Is It And How Many Patients Are Eligible: A New Horizon For Vascular Specialists |
| Presenter(s):Seshadri Raju, MD | |
| 1:18 PM - 1:23 PM | Important Vascular Changes During Pregnancy And Their Implications For The Vascular Surgeon And Vascular Specialist |
| Presenter(s):Joann Lohr, MD | |
| 1:24 PM - 1:29 PM | When Should Acute DVT Be Treated Aggressively By Endovascular Means And When Is Conservative Treatment Best: What Is The Optimal Treatment |
| Presenter(s):Cees H.A. Wittens, MD, PhD | |
| 1:30 PM - 1:35 PM | What The Vascular Specialist Needs To Know About The Newer Oral Anticoagulants, Their Pitfalls And How To Use Them |
| Presenter(s):Don Poldermans, MD | |
| View Abstract | |
| 1:36 PM - 1:41 PM | New Techniques For Treating Central Vein Occlusions And SVC Syndrome Which Minimize The Use Of Stents: Why It Is Worthwhile |
| Presenter(s):Thomas O. McNamara, MD | |
| 1:42 PM - 1:47 PM | Aggressive Treatment Of Central Vein Stenoses In Patients With Threatened A-V Dialysis Access |
| Presenter(s):Karl A. Illig, MD | |
| 1:48 PM - 1:53 PM | FDA Perspective On Evaluating Procedures And Devices For Treating Venous Disease – Including CCSVI |
| Presenter(s):Kenneth J. Cavanaugh, Jr., PhD / J. Pablo Morales, MD | |
| 1:54 PM - 2:04 PM | Panel Discussion |
| END OF SESSION 40 | |
| SESSION 41 SCHEDULE | |
|
Wednesday
SESSION 41:
CALF DEEP VEIN THROMBOSIS (DVT) AND SUPERFICIAL VEIN THROMBOSIS
Moderators:J. Leonel Villavicencio, MD / Cees H.A. Wittens, MD, PhD
|
|
| x | |
| 2:05 PM - 2:10 PM | Acute Saphenous Vein Thrombosis: Anticoagulate, Ligate, Strip Or Burn |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
| 2:11 PM - 2:16 PM | DEBATE: Infrapopliteal DVT Should Not Be Treated Aggressively |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Abstract | |
| 2:17 PM - 2:22 AM | DEBATE: Infrapopliteal DVT Is Dangerous And Should Be Treated |
| Presenter(s):Joann Lohr, MD | |
| 2:23 PM - 2:28 PM | All Calf DVTs Are Not The Same: A Case For SELECTIVE Treatment |
| Presenter(s):Elna M. Masuda, MD | |
| 2:29 PM - 2:34 PM | A United States Survey On The Management Of Below Knee DVT |
| Presenter(s):Ross Milner, MD | |
| 2:35 PM - 2:40 PM | Should You Treat Outpatient Intramuscular DVT: With What And For How Long |
| Presenter(s):Robert B. McLafferty, MD | |
| 2:41 PM - 2:46 PM | Mechanism Of Venous Valve Closure And The Role Of The Valves In The Venous Circulation |
| Presenter(s):Fedor Lurie, MD, PhD | |
| 2:47 PM - 2:52 PM | Why Did Venous Valve Repair Disappear In The US |
| Presenter(s):Seshadri Raju, MD | |
| 2:53 PM - 2:58 PM | Deep Venous Valvular Reconstruction: How To Do It And Results |
| Presenter(s):Marzia Lugli, MD | |
| 2:59 PM - 3:04 PM | Deep Venous Valve Reconstruction Is Underutilized |
| Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
| View Abstract | |
| 3:05 PM - 3:10 PM | Deep Venous Valves: Why Are They Important And When And How Should They Be Treated |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Abstract | |
| 3:11 PM - 3:16 PM | Why And How To Treat Popliteal Vein Aneurysms: The Lateral Approach May Help |
| Presenter(s):Charles Strom, MD / Frank B. Pomposelli, MD | |
| 3:17 PM - 3:32 PM | Panel Discussion |
| END OF SESSION 41 | |
| SESSION 42 SCHEDULE | |
|
Wednesday
SESSION 42:
INTERESTING TOPICS, CASES AND LITERATURE REVIEWS (10-MINUTE TALKS)
|
|
| x | |
| 3:33 PM - 3:43 PM | What We Learned From The Boston Marathon Civilian Injuries |
| Presenter(s):Glenn M. LaMuraglia, MD | |
| 3:44 PM - 3:54 PM | Major Venous Injuries: Lessons Learned From Iraq And Afghanistan |
| Presenter(s):Todd E. Rasmussen, MD, FACS | |
| 3:55 PM - 4:05 PM | Common Femoral Vein Endovenectomy With Endoluminal Iliac Vein Recanalization For Post-Thrombotic Syndrome: Indications And Tips And Tricks |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| 4:06 PM - 4:16 PM | Iliocaval IVUS And Stenting: Tips And Tricks |
| Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
| 4:17 PM - 4:27 PM | Crossing Ilio-Femoral CTOs: What Approach, Tips And Tricks |
| Presenter(s):Gerard J. O'Sullivan, MD | |
| 4:28 PM - 4:38 PM | For Near Fatal PE And Possibly Central DVT: A New Device, Tips And Tricks |
| Presenter(s):Christopher J. Kwolek, MD | |
| 4:39 PM - 4:49 PM | Resection Of IVC For Renal Cell Cancer: Tips And Tricks |
| Presenter(s):R. Clement Darling III, MD | |
| 4:50 PM - 5:00 PM | Deep Venous Reconstruction: Tips And Tricks – A Pictorial Video Demonstration |
| Presenter(s):Peter Gloviczki, MD | |
| 5:00 PM - 5:15 PM | Panel Discussion End of Program C |
| END OF SESSION 42 | |